Optimizing Treatment Strategies for Adult Attention-Deficit Hyperactivity Disorder (ADHD) (R01 Clinical Trial Required)

The National Institutes of Health (NIH) is soliciting applications for a research grant focused on optimizing treatment strategies for adult Attention-Deficit Hyperactivity Disorder (ADHD). The grant aims to support the development of evidence-based treatment approaches that go beyond stimulant medications, utilizing non-stimulant medications, psychosocial interventions, and device-based treatments. The goal is to provide effective treatment options for adults with ADHD, particularly in situations where stimulant monotherapy is insufficiently effective, difficult to tolerate, or undesirable. • The grant will support clinical trials testing non-stimulant medications, psychosocial interventions, and device-based approaches, sequentially or in combination, to augment or replace stimulants. • Applications from a variety of eligible organizations, including small businesses, nonprofits, and institutions of higher education, are encouraged. • The estimated funding for this grant is $3,000,000, with an anticipated 4 awards. • The project duration is not explicitly stated, but based on the award date and the nature of the research grant, it can be estimated to last around 1-2 years.